Pure Global AI
NCT06409065Recruiting

Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

M.D. Anderson Cancer CenterClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Cancer
Drug/Device/Intervention
Meditation Program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
M.D. Anderson Cancer Center
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 09, 2024
End date
Feb 01, 2030
Enrollment
400 participants
Primary outcome

Depressive Symptoms

Summary

The goal of this behavioral research study is to learn about the effects of two different
 supportive care programs on patients' and their family caregivers' psychological wellbeing
 and overall quality of life.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409065
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06409065 through Pure Global AI's free database. This phase not specified trial is sponsored by M.D. Anderson Cancer Center and is currently Recruiting. The study focuses on Cancer. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.